Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome

Clinical Endocrinology

Volumn 81, Issue 4, 2014, Pages 529-535

  Orlik, Bartłomiej ^a   Madej, Paweł ^a   Owczarek, Aleksander ^a   Skałba, Piotr ^a   Chudek, Jerzy ^a   Olszanecka Glinianowicz, Magdalena ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; OMENTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE DYSFUNCTION; ADULT; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL DISEASE BY ANATOMICAL STRUCTURE; PROTEIN BLOOD LEVEL; STROMA CELL; WAIST CIRCUMFERENCE; BLOOD; METABOLISM; PATHOLOGY;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; OBESITY; POLYCYSTIC OVARY SYNDROME;

EID: 84908109642     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12381     Document Type: Article

References (32)

1. Diamanti-Kandarakis, E. & Papavassiliou, A.G. (2006) Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends in Molecular Medicine, 12, 324-332.
2. Escobar-Morreale, H. & San Millán, J.L. (2007) Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism, 18, 266-272.
3. Diamanti-Kandarakis, E. (2007) Role of obesity and adiposity in polycystic ovary syndrome. International Journal of Obesity (London), 31(Suppl 2), S8-S13.
4. Torres-Leal, F.L., Fonseca-Alaniz, M.H., Rogero, M.M. et al. (2010) The role of inflamed adipose tissue in the insulin resistance. Cell Biochemistry and Function, 28, 623-631.
5. Villa, J. & Pratiev, R.E. (2011) Adipose tissue dysfunction in polycystic ovary syndrome. Current Diabetes Reports, 11, 179-184.
6. Olszanecka-Glinianowicz, M., Banas̈, M., Zahorska-Markiewicz, B. et al. (2007) Is the polycystic ovary syndrome associated with chronic inflammation per se? European Journal of Obstetrics, Gynecology, and Reproductive Biology, 133, 197-202.
7. Olszanecka-Glinianowicz, M., Kuglin, D., Da¸bkowska-Huć, A. et al. (2011) Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 154, 51-56.
8. Olszanecka-Glinianowicz, M., Madej, P., Zdun, D. et al. (2012) Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? European Journal of Obstetrics, Gynecology, and Reproductive Biology, 162, 55-61.
9. Olszanecka-Glinianowicz, M., Madej, P., Nylec, M. et al. (2013) Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clinical Endocrinology (Oxford), 79, 238-242.
10. Sone, M., Nagta, H., Takekoshi, S. et al. (2001) Expression and localization of leptin receptor in the normal rat pituitary gland. Cell Tissue Research, 305, 351-356.
11. Psilopanagiotio, A., Papadaki, H., Kranioti, E.F. et al. (2009) Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology, 89, 38-47.
12. Taheri, S., Murphy, K., Cohen, M. et al. (2002) The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochemical and Biophysical Research Communication, 291, 1208-1212.
13. Reaux-Le Goazigo, A., Alvear-Perez, R., Zizzari, P. et al. (2007) Cellular localization of apelin and its receptor in the anteriorpituitary: evidence for a direct stimulatory action of apelin on ACTH release. American Journal of Physiology. Endocrinology and Metabolism, 292, E7-E15.
14. Tersigni, C., Di Nicuolo, F., D'Ippolito, S. et al. (2011) Adipokines: new emerging roles in fertility and reproduction. Obstetrical & Gynecological Survey, 66, 47-63.
15. Kadowski, T. & Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocrine Reviews, 26, 439-451.
16. Yamauchi, T., Kamon, J., Minokoshi, Y. et al. (2002) Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8, 1288-1295.
17. Yang, R.Z., Lee, M.J., Hu, H. et al. (2006) Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology. Endocrinology and Metabolism, 290, 1253-1261.
18. Ouchi, N., Kihara, S., Arita, Y. et al. (2000) Adiponectin an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation, 102, 1296-1301.
19. Yamawaki, H., Kuramoto, J., Kameshima, S. et al. (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochemical and Biophysical Research Communications, 408, 339-343.
20. Geer, E.B. & Shen, W. (2009) Gander differences in insulin resistance, body composition and energy balance. Gender Medicine, 6 (Suppl 1), 60-75.
21. De Souza Batista, C.M., Yang, R.Z., Lee, M.J. et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56, 1655-1661.
22. Sherer, P.E. (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 55, 1537-1545.
23. Ardawi, M.S. & Rouzi, A.A. (2005) Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility, 83, 1708-1716.
24. Tan, B.K., Adya, R., Furhatullah, S. et al. (2008) Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes, 57, 801-808.
25. Mahde, A., Sheker, M. & Al-Mashhadani, Z. (2009) Study of omentin1 and other adipokines and hormones in PCOS patients. Oman Medical Journal, 24, 108-118.
26. Tan, B.K., Adya, R., Furhatullah, S. et al. (2010) Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes, 59, 3023-3031.
27. Sharifi, F., Hajihosseini, R., Mazloomi, S. et al. (2010) Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index. Metabolic Syndrome and Related Disorders, 8, 47-52.
28. Choi, J.H., Rhee, E.J., Kim, K.H. et al. (2011) Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. European Journal of Endocrinology, 165, 789-796.
29. Akbarzadeh, S., Ghasemi, S., Kalantarhormozi, M. et al. (2012) Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI. Gynecological Endocrinology, 28, 521-524.
30. The Rotterdam ESHRE/ASRM-Sponsored P.C.O.S. Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
31. Auguet, T., Quintero, Y., Riesco, D. et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Medical Genetics, 12, 60.
32. Cai, R.C., Wei, L., Di, J.Z. et al. (2009) [Expression of omentin in adipose tissues in obese and type 2 diabetic patients]. Zhonghua Yi Xue Za Zhi, 89, 381-384.